TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Active Malaria Epidemiology Cohort Study With Evaluation of a 2 Day Versus 3 Day Treatment Regimen of Dihydroartemisinin (DHA)-Piperaquine for Patients With Uncomplicated Malaria
Brief Summary: An observational cohort and malaria treatment study in Cambodia.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sulphadoxine-pyrimethamine (day 1: 500mg S&25mg P/20 kg), Drug: Artesunate (day 1,2,3: 4 mg/kg), Drug: Primaquine-base (day 3: 0.75 mg/kg) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo tablets | Intervention Type: DRUG; Name: Sulphadoxine-pyrimethamine (day 1: 500mg S&25mg P/20 kg); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Artesunate (day 1,2,3: 4 mg/kg); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Primaquine-base (day 3: 0.75 mg/kg); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo tablets; Assigned to Arm(s): 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: sulfadoxine-pyrimethamine (SP) plus artesunate (AS) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: primaquine (PQ) plus SP+AS | Intervention Type: DRUG; Name: sulfadoxine-pyrimethamine (SP) plus artesunate (AS); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: primaquine (PQ) plus SP+AS; Assigned to Arm(s): 2
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: chlorproguanil-dapsone-artesunate, Drug: chlorproguanil-dapsone | Intervention Type: DRUG; Name: chlorproguanil-dapsone-artesunate; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: chlorproguanil-dapsone; Assigned to Arm(s): Arm 1
D: Arm Label: 3 day therapy; Type: EXPERIMENTAL; Interventions: Drug: Dihydroartemisinin piperaquine | Arm Label: 2 day therapy; Type: EXPERIMENTAL; Interventions: Drug: Dihydroartemisinin piperaquine | Intervention Type: DRUG; Name: Dihydroartemisinin piperaquine; Assigned to Arm(s): 2 day therapy, 3 day therapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Phosphodiesterase-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon, Double Blind, Randomized, Cross-over Trial
Brief Summary: The prevalence of Raynaud phenomenon (RP), a reversible vaso-constriction with skin discoloration, is 5-10% in general population. Often conventional measures such as warming up or minimizing exposure to cold are not enough and many patients require treatment with a vasodilator therapy. A recent study showed a good efficacy and safety profile of sildenafil, a selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in RP.

Here, the investigators aim to examine the efficacy and safety of Udenafil, a newer PDE5 inhibitor, as compared to amlodipine, a well known calcium channel blocker, in the treatment of secondary RP in Korean patients.


Options:
A: Arm Label: Vardenafil 10 mg bid; Type: EXPERIMENTAL; Interventions: Drug: vardenafil, Drug: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: vardenafil, Drug: Placebo | Intervention Type: DRUG; Name: vardenafil; Assigned to Arm(s): Placebo, Vardenafil 10 mg bid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo, Vardenafil 10 mg bid
B: Arm Label: Sildenafil 80 mg; Type: EXPERIMENTAL; Interventions: Drug: Sildenafil 80 mg | Arm Label: Sildenafil 40 mg; Type: EXPERIMENTAL; Interventions: Drug: Sildenafil 40 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sildenafil 40 mg; Assigned to Arm(s): Sildenafil 40 mg | Intervention Type: DRUG; Name: Sildenafil 80 mg; Assigned to Arm(s): Sildenafil 80 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Amlodipine-Udenafil (AU) arm; Type: EXPERIMENTAL; Interventions: Drug: Udenafil or Amlodipine | Arm Label: Udenafil-Amlodipine (UA) arm; Type: EXPERIMENTAL; Interventions: Drug: Udenafil or Amlodipine | Intervention Type: DRUG; Name: Udenafil or Amlodipine; Assigned to Arm(s): Amlodipine-Udenafil (AU) arm, Udenafil-Amlodipine (UA) arm
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Tadalafil | Intervention Type: DRUG; Name: Tadalafil; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
Brief Summary: The primary purpose of this study is to assess the efficacy of the mobile phone-based physical activity intervention on increasing physical activity compared to the control group.


Options:
A: Arm Label: Tailored Physical Activity Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Physical Activity Intervention | Arm Label: No Tailored Physical Activity Intervention Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored Physical Activity Intervention; Assigned to Arm(s): Tailored Physical Activity Intervention Group
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mini Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Mini Booster | Arm Label: Full Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Full Booster | Intervention Type: BEHAVIORAL; Name: Mini Booster; Assigned to Arm(s): Mini Booster | Intervention Type: BEHAVIORAL; Name: Full Booster; Assigned to Arm(s): Full Booster
C: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer
D: Arm Label: 1- physical activity tailored; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity tailored | Arm Label: 2 - physical activity standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: physical activity standard | Intervention Type: BEHAVIORAL; Name: physical activity tailored; Assigned to Arm(s): 1- physical activity tailored | Intervention Type: BEHAVIORAL; Name: physical activity standard; Assigned to Arm(s): 2 - physical activity standard

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
Brief Summary: The primary purpose of this study is to assess the efficacy of the mobile phone-based physical activity intervention on increasing physical activity compared to the control group.


Options:
A: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mini Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Mini Booster | Arm Label: Full Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Full Booster | Intervention Type: BEHAVIORAL; Name: Mini Booster; Assigned to Arm(s): Mini Booster | Intervention Type: BEHAVIORAL; Name: Full Booster; Assigned to Arm(s): Full Booster
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Modified DESMOND education and ongoing support | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Modified DESMOND education and ongoing support; Assigned to Arm(s): 1
D: Arm Label: High reinforcement cessation program; Type: EXPERIMENTAL; Interventions: Behavioral: high reinforcement cessation program | Arm Label: Low reinforcement cessation program; Type: EXPERIMENTAL; Interventions: Behavioral: low reinforcement cessation program | Intervention Type: BEHAVIORAL; Name: high reinforcement cessation program; Assigned to Arm(s): High reinforcement cessation program | Intervention Type: BEHAVIORAL; Name: low reinforcement cessation program; Assigned to Arm(s): Low reinforcement cessation program

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
Brief Summary: The primary purpose of this study is to assess the efficacy of the mobile phone-based physical activity intervention on increasing physical activity compared to the control group.


Options:
A: Intervention Type: BEHAVIORAL; Name: Physical activity (PA) and immigrants; Assigned to Arm(s): N/A
B: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer
C: Intervention Type: BEHAVIORAL; Name: Internet and print-based interventions; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
Brief Summary: The primary purpose of this study is to assess the efficacy of the mobile phone-based physical activity intervention on increasing physical activity compared to the control group.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mini Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Mini Booster | Arm Label: Full Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Full Booster | Intervention Type: BEHAVIORAL; Name: Mini Booster; Assigned to Arm(s): Mini Booster | Intervention Type: BEHAVIORAL; Name: Full Booster; Assigned to Arm(s): Full Booster
B: Intervention Type: BEHAVIORAL; Name: Internet and print-based interventions; Assigned to Arm(s): N/A
C: Arm Label: 1- physical activity tailored; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity tailored | Arm Label: 2 - physical activity standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: physical activity standard | Intervention Type: BEHAVIORAL; Name: physical activity tailored; Assigned to Arm(s): 1- physical activity tailored | Intervention Type: BEHAVIORAL; Name: physical activity standard; Assigned to Arm(s): 2 - physical activity standard
D: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy (Ranibizumab 0.5 mg Intravitreal Injections) Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP (Monotherapy) in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy
Brief Summary: The purpose of this trial is to evaluate safety and to compare the efficacy of intravitreous injection of ranibizumab alone (0.5 mg), versus combination of intravitreous injection of ranibizumab (0.5 mg) plus panretinal photocoagulation, versus panretinal photocoagulation alone in the regression of retinal neovascularization in eyes with high-risk proliferative diabetic retinopathy.


Options:
A: Arm Label: Saline Injection; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Arm Label: Ranibizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ranibizumab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline Injection
B: Arm Label: intravitreal bevacizumab injections and then rescue; Type: ACTIVE_COMPARATOR; Interventions: Drug: receive 4 monthly IVB injections and then rescue IVB | Arm Label: PRP group; Type: ACTIVE_COMPARATOR; Interventions: Drug: PRP group | Arm Label: IVB injections and a modified laser; Type: ACTIVE_COMPARATOR; Interventions: Drug: IVB injections and a modified laser | Intervention Type: DRUG; Name: receive 4 monthly IVB injections and then rescue IVB; Assigned to Arm(s): intravitreal bevacizumab injections and then rescue | Intervention Type: DRUG; Name: PRP group; Assigned to Arm(s): PRP group | Intervention Type: DRUG; Name: IVB injections and a modified laser; Assigned to Arm(s): IVB injections and a modified laser
C: Arm Label: Arm A: 0.3 mg Ranibizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ranibizumab | Arm Label: Arm B: 1.5 mg Faricimab; Type: EXPERIMENTAL; Interventions: Drug: Faricimab | Arm Label: Arm C: 6 mg Faricimab; Type: EXPERIMENTAL; Interventions: Drug: Faricimab | Intervention Type: DRUG; Name: Faricimab; Assigned to Arm(s): Arm B: 1.5 mg Faricimab, Arm C: 6 mg Faricimab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Arm A: 0.3 mg Ranibizumab
D: Arm Label: Panretinal Photocoagulation (PRP); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Panretinal Photocoagulation (PRP) | Arm Label: Ranibizumab; Type: EXPERIMENTAL; Interventions: Drug: Intravitreous injection of ranibizumab | Arm Label: Ranibizumab + Panretinal Photocoagulation (PRP); Type: EXPERIMENTAL; Interventions: Procedure: Panretinal Photocoagulation (PRP), Drug: Intravitreous injection of ranibizumab | Intervention Type: PROCEDURE; Name: Panretinal Photocoagulation (PRP); Assigned to Arm(s): Panretinal Photocoagulation (PRP), Ranibizumab + Panretinal Photocoagulation (PRP) | Intervention Type: DRUG; Name: Intravitreous injection of ranibizumab; Assigned to Arm(s): Ranibizumab, Ranibizumab + Panretinal Photocoagulation (PRP)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Brief Summary: The purpose of this study is to determine whether dexpramipexole (150 mg twice daily) is safe and effective in the treatment of Amyotrophic Lateral Sclerosis (ALS).


Options:
A: Arm Label: Dexpramipexole; Type: EXPERIMENTAL; Interventions: Drug: Dexpramipexole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dexpramipexole; Assigned to Arm(s): Dexpramipexole | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard Care | Arm Label: Extended Care Management; Type: EXPERIMENTAL; Interventions: Other: Extended Care Management | Intervention Type: OTHER; Name: Extended Care Management; Assigned to Arm(s): Extended Care Management | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
C: Arm Label: UC; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TM; Type: EXPERIMENTAL; Interventions: Other: Telemonitoring | Intervention Type: OTHER; Name: Telemonitoring; Assigned to Arm(s): TM
D: Arm Label: Basic HEALTH; Type: EXPERIMENTAL; Interventions: Behavioral: RCT1 | Arm Label: Interactive Internet; Type: EXPERIMENTAL; Interventions: Behavioral: RCT2 | Arm Label: Behavioral Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: RCT3 | Intervention Type: BEHAVIORAL; Name: RCT1; Assigned to Arm(s): Basic HEALTH | Intervention Type: BEHAVIORAL; Name: RCT2; Assigned to Arm(s): Interactive Internet | Intervention Type: BEHAVIORAL; Name: RCT3; Assigned to Arm(s): Behavioral Counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Education Interventions Model for Rational Drug Use
Brief Summary: The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.


Options:
A: Arm Label: experimental; Type: EXPERIMENTAL; Interventions: Other: intensive implementation programme | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: control | Intervention Type: OTHER; Name: intensive implementation programme; Assigned to Arm(s): experimental | Intervention Type: OTHER; Name: control; Assigned to Arm(s): control
B: Arm Label: Pharmaceutical Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education interventional | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education interventional; Assigned to Arm(s): Pharmaceutical Education
C: Arm Label: Feedback; Type: EXPERIMENTAL; Interventions: Device: Feedback | Arm Label: Demonstration; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Feedback; Assigned to Arm(s): Feedback | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Demonstration
D: Arm Label: TEAM Care; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacy TEAM monitoring and counseling | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pharmacy TEAM monitoring and counseling; Assigned to Arm(s): TEAM Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Education Interventions Model for Rational Drug Use
Brief Summary: The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.


Options:
A: Arm Label: Pharmaceutical Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education interventional | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education interventional; Assigned to Arm(s): Pharmaceutical Education
B: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Education | Arm Label: Pharmaceutical Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Pharmaceutical Care | Intervention Type: OTHER; Name: Pharmaceutical Care; Assigned to Arm(s): Pharmaceutical Care | Intervention Type: OTHER; Name: Education; Assigned to Arm(s): Control
C: Arm Label: Pharmacist-Physician Collaborative Medication Management; Type: EXPERIMENTAL; Interventions: Other: Pharmacist-Physician Collaborative Medication Therapy Management | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmacist-Physician Collaborative Medication Therapy Management; Assigned to Arm(s): Pharmacist-Physician Collaborative Medication Management
D: Intervention Type: BEHAVIORAL; Name: Home BP;secure messaging;pharmaceutical care;; Assigned to Arm(s): N/A

Answer: A